108 related articles for article (PubMed ID: 31101761)
1. Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis.
Saint-Germain E; Mignacca L; Huot G; Acevedo M; Moineau-Vallée K; Calabrese V; Bourdeau V; Rowell MC; Ilangumaran S; Lessard F; Ferbeyre G
Cancer Res; 2019 Jul; 79(13):3306-3319. PubMed ID: 31101761
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 links cytokine signaling to p53 and senescence.
Calabrese V; Mallette FA; DeschĂȘnes-Simard X; Ramanathan S; Gagnon J; Moores A; Ilangumaran S; Ferbeyre G
Mol Cell; 2009 Dec; 36(5):754-67. PubMed ID: 20005840
[TBL] [Abstract][Full Text] [Related]
3. SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes.
Saint-Germain E; Mignacca L; Vernier M; Bobbala D; Ilangumaran S; Ferbeyre G
Aging (Albany NY); 2017 Oct; 9(10):2137-2162. PubMed ID: 29081404
[TBL] [Abstract][Full Text] [Related]
4. SOCS1: phosphorylation, dimerization and tumor suppression.
Lessard F; Saint-Germain E; Mignacca L; Ferbeyre G
Oncoscience; 2019 Nov; 6(11-12):386-389. PubMed ID: 31984217
[TBL] [Abstract][Full Text] [Related]
5. The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo.
Doggett K; Keating N; Dehkhoda F; Bidgood GM; Meza Guzman LG; Leong E; Kueh A; Nicola NA; Kershaw NJ; Babon JJ; Alexander WS; Nicholson SE
Cytokine; 2023 May; 165():156167. PubMed ID: 36934508
[TBL] [Abstract][Full Text] [Related]
6. The suppressor of cytokine signaling SOCS1 promotes apoptosis of intestinal epithelial cells via p53 signaling in Crohn's disease.
Cui X; Shan X; Qian J; Ji Q; Wang L; Wang X; Li M; Ding H; Liu Q; Chen L; Zhang D; Ni R
Exp Mol Pathol; 2016 Aug; 101(1):1-11. PubMed ID: 27236107
[TBL] [Abstract][Full Text] [Related]
7. SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation.
Santharam MA; Shukla A; Ihsan AU; Cloutier M; Levesque D; Ramanathan S; Boisvert FM; Ilangumaran S
Biochimie; 2021 Mar; 182():185-196. PubMed ID: 33493533
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation.
Jung SH; Kim SM; Lee CE
Oncotarget; 2016 Sep; 7(38):62559-62571. PubMed ID: 27613835
[TBL] [Abstract][Full Text] [Related]
9. Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers.
Mignacca L; Saint-Germain E; Benoit A; Bourdeau V; Moro A; Ferbeyre G
Cytokine; 2016 Jun; 82():80-6. PubMed ID: 26841929
[TBL] [Abstract][Full Text] [Related]
10. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.
Venkitachalam S; Chueh FY; Leong KF; Pabich S; Yu CL
Oncol Rep; 2011 Mar; 25(3):677-83. PubMed ID: 21234523
[TBL] [Abstract][Full Text] [Related]
13. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
14. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
15. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
16. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.
Mallette FA; Calabrese V; Ilangumaran S; Ferbeyre G
Aging (Albany NY); 2010 Jul; 2(7):445-52. PubMed ID: 20622265
[TBL] [Abstract][Full Text] [Related]
17. Identification of a nuclear localization signal in suppressor of cytokine signaling 1.
Baetz A; Koelsche C; Strebovsky J; Heeg K; Dalpke AH
FASEB J; 2008 Dec; 22(12):4296-305. PubMed ID: 18725457
[TBL] [Abstract][Full Text] [Related]
18. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.
Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J
Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]